DAFNA Capital Management LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
DAFNA Capital Management LLC disclosed 84 US equity positions worth $423.3m in its Q3 2024 13F filing. The largest position was XBI at 9.4% of the reported book, followed by STXS and RVMD.
What did DAFNA Capital Management LLC own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | XBI SPDR S&P BIOTECH ETF | 9.4% | $39.7m | 401,505 | – | ||
| 2 | STXS STEREOTAXIS INC | 6.6% | $27.9m | 13,680,554 | – | ||
| 3 | RVMD REVOLUTION MEDICINES INC | Healthcare | 5.5% | $23.5m | 517,994 | – | |
| 4 | CYTK CYTOKINETICS INC | Healthcare | 5.0% | $21.0m | 398,100 | – | |
| 5 | MERUS N V | 4.9% | $20.6m | 412,573 | – | ||
| 6 | ATRC ATRICURE INC | Healthcare | 4.3% | $18.0m | 641,673 | – | |
| 7 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 3.5% | $14.9m | 471,410 | – | |
| 8 | IBB ISHARES NASDAQ BIOTECH INDX | 3.5% | $14.9m | 102,500 | – | ||
| 9 | ASND ASCENDIS PHARMA A/S | Healthcare | 3.2% | $13.4m | 89,572 | – | |
| 10 | AXGN AXOGEN INC | Healthcare | 3.1% | $13.1m | 935,894 | – | |
| 11 | 2655787D BLUEPRINT MEDICINES CORP | 2.7% | $11.3m | 121,763 | – | ||
| 12 | XENE XENON PHARMACEUTICALS INC | Healthcare | 2.5% | $10.8m | 273,739 | – | |
| 13 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 2.5% | $10.5m | 750,363 | – | ||
| 14 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 2.4% | $10.1m | 526,702 | – | |
| 15 | BHVN BIOHAVEN LTD | Healthcare | 2.2% | $9.4m | 187,130 | – | |
| 16 | TNDM TANDEM DIABETES CARE INC | Healthcare | 2.0% | $8.7m | 204,208 | – | |
| 17 | 4XC1 KALVISTA PHARMACEUTICALS INC | 2.0% | $8.4m | 723,678 | – | ||
| 18 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 1.9% | $8.0m | 69,615 | – | |
| 19 | KURA KURA ONCOLOGY INC | Healthcare | 1.9% | $8.0m | 408,368 | – | |
| 20 | VKTX VIKING THERAPEUTICS INC | Healthcare | 1.9% | $8.0m | 125,616 | – | |
| 21 | EWTX EDGEWISE THERAPEUTICS INC | 1.4% | $6.1m | 227,906 | – | ||
| 22 | URGN UROGEN PHARMA LTD | Healthcare | 1.4% | $5.8m | 458,915 | – | |
| 23 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.2% | $5.1m | 667,000 | – | |
| 24 | ASND ASCENDIS PHARMA A/S | 1.1% | $4.7m | 4,000,000 | – | ||
| 25 | DXCM DEXCOM INC | Healthcare | 1.0% | $4.4m | 65,552 | – | |
| 26 | KROS KEROS THERAPEUTICS INC | Healthcare | 1.0% | $4.3m | 73,754 | – | |
| 27 | ALEC ALECTOR INC | Healthcare | 1.0% | $4.3m | 912,928 | – | |
| 28 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 0.9% | $3.9m | 256,717 | – | |
| 29 | LKFT GALAPAGOS NV | Healthcare | 0.9% | $3.7m | 130,175 | – | |
| 30 | PODD INSULET CORP | Healthcare | 0.9% | $3.7m | 15,900 | – | |
| 31 | ALKS ALKERMES PLC | Healthcare | 0.8% | $3.4m | 120,700 | – | |
| 32 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 0.8% | $3.2m | 494,274 | – | |
| 33 | CATX PERSPECTIVE THERAPEUTICS INC | 0.7% | $3.1m | 230,322 | – | ||
| 34 | TSVT* 2SEVENTY BIO INC | 0.7% | $3.0m | 630,029 | – | ||
| 35 | ACELYRIN INC | 0.7% | $3.0m | 602,894 | – | ||
| 36 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 0.7% | $2.9m | 1,050,118 | – | |
| 37 | AQST AQUESTIVE THERAPEUTICS INC | 0.7% | $2.9m | 589,561 | – | ||
| 38 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 0.7% | $2.9m | 1,704,232 | – | |
| 39 | CATBUSD ASTRIA THERAPEUTICS INC | 0.7% | $2.8m | 254,165 | – | ||
| 40 | BCYC BICYCLE THERAPEUTICS PLC | Healthcare | 0.7% | $2.8m | 122,200 | – | |
| 41 | STOK STOKE THERAPEUTICS INC | Healthcare | 0.6% | $2.5m | 207,427 | – | |
| 42 | BWAY BRAINSWAY LTD | 0.5% | $2.3m | 251,346 | – | ||
| 43 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.5% | $2.3m | 250,583 | – | |
| 44 | ARAY ACCURAY INC | Healthcare | 0.5% | $2.2m | 1,222,358 | – | |
| 45 | SPRY ARS PHARMACEUTICALS INC | Healthcare | 0.5% | $2.2m | 148,294 | – | |
| 46 | INGN INOGEN INC | Healthcare | 0.5% | $2.0m | 208,790 | – | |
| 47 | CNTA CENTESSA PHARMACEUTICALS PLC | 0.5% | $1.9m | 120,351 | – | ||
| 48 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.4% | $1.8m | 146,500 | – | |
| 49 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 0.4% | $1.8m | 486,667 | – | |
| 50 | IMTX IMMATICS NV | Healthcare | 0.4% | $1.7m | 145,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.